Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wilpart, M.
Right arrow Articles by Roberfroid, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilpart, M.
Right arrow Articles by Roberfroid, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1983 Oxford University Press

research-article

Mutagenicity of 1,2-dimethylhydrazine towards Salmonella typhimurium, co-mutagenic effect of secondary biliary acids

M. Wilpart, P. Mainguet, A. Maskens and M. Roberfroid 1

Research Group on Diet and Cancer, Unité de Biochimie Toxicologique et Cancérologique, Université Catholique de Louvain U.C.L. 73.69, B-1200 Brussels, Belgium

1To whom correspondence and reprint requests should be addressed

Even though 1,2-dimethylhydrazine (DMH) is highly carcinogenic in experimental animals, it has not been shown to be clearly mutagenic in any of the short term tests in vitro. The present report demonstrates that DMH is mutagenic in the Ames test when it is incubated together with lithocholic or deoxycholic acid with or without metabolic activation. Such a co-mutagenic effect seems to be restricted to the secondary biliary acids since neither cholic nor chenodeoxycholic acid had the same activity. The secondary biliary acids are present in the colon where they are formed by bacteria. Such a comutagenic effect could thus be of importance with regard to the carcinogenic activity of DMH. It could also be relevant to colon carcinogenesis in humans.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Tarao, S. Fujiyama, S. Ohkawa, K. Miyakawa, S. Tamai, S. Hirokawa, T. Masaki, and K. Tanaka
Ursodiol Use Is Possibly Associated with Lower Incidence of Hepatocellular Carcinoma in Hepatitis C Virus-Associated Liver Cirrhosis
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 164 - 169.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. T. Hawk and J. L. Viner
Chemoprevention in Ulcerative Colitis: Narrowing the Gap between Clinical Practice and Research
Ann Intern Med, January 16, 2001; 134(2): 158 - 160.
[Full Text] [PDF]


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
M.F. Chaplin
Review : Bile acids, fibre and colon cancer: the story unfolds
Perspectives in Public Health, February 1, 1998; 118(1): 53 - 61.
[Abstract]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.